- Early-stage unfavorable cHL; Peter Borchmann
- KEYNOTE 204; Pier Luigi Zinzani
- Hodgkin’s Lymphoma in the era of targeted therapy; Peter Johnson
By choosing to continue, you are confirming that you are a healthcare professional
Keep up to date with all the latest news with our monthly newsletter